Trial Outcomes & Findings for COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy (NCT NCT05961332)

NCT ID: NCT05961332

Last Updated: 2026-07-10

Results Overview

Graders will independently measure area of GA from images of each device. The measurements (in mm²) will be compared between the devices.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

62 participants

Primary outcome timeframe

Up to 75 minutes

Results posted on

2026-07-10

Participant Flow

Unit of analysis: eyes

Participant milestones

Participant milestones
Measure
Fundus Autofluorescence (FAF) Imaging
Spectralis FAF imaging: Spectralis is a scanning laser ophthalmoscope which uses a blue light excitation wavelength of 488nm and a 500nm barrier filter to produce FAF images. Spectralis images 20-55 degrees of the retina. Optos imaging: Optos is an ultrawide field imaging platform which images up to 200 degrees of the retina. It uses both a green-light excitation wavelength of 532nm and a red-light excitation wavelength of 633nm with an emission filter of greater than 540nm to produce FAF images. Zeiss Clarus 700 imaging: Zeiss Clarus 700 is an ultrawide field imaging system with similar retinal coverage to that of Optos. It uses Broad Line Fundus Imaging to produce blue FAF images at excitation wavelengths of 435-500nm and green FAF images at wavelengths of 500-585nm
Overall Study
STARTED
62 124
Overall Study
COMPLETED
39 61
Overall Study
NOT COMPLETED
23 63

Reasons for withdrawal

Reasons for withdrawal
Measure
Fundus Autofluorescence (FAF) Imaging
Spectralis FAF imaging: Spectralis is a scanning laser ophthalmoscope which uses a blue light excitation wavelength of 488nm and a 500nm barrier filter to produce FAF images. Spectralis images 20-55 degrees of the retina. Optos imaging: Optos is an ultrawide field imaging platform which images up to 200 degrees of the retina. It uses both a green-light excitation wavelength of 532nm and a red-light excitation wavelength of 633nm with an emission filter of greater than 540nm to produce FAF images. Zeiss Clarus 700 imaging: Zeiss Clarus 700 is an ultrawide field imaging system with similar retinal coverage to that of Optos. It uses Broad Line Fundus Imaging to produce blue FAF images at excitation wavelengths of 435-500nm and green FAF images at wavelengths of 500-585nm
Overall Study
excluded for eyes that did not meet the inclusion criteria per clinician or reading center grade
23

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Fundus Autofluorescence (FAF) Imaging
n=62 Participants
Spectralis FAF imaging: Spectralis is a scanning laser ophthalmoscope which uses a blue light excitation wavelength of 488nm and a 500nm barrier filter to produce FAF images. Spectralis images 20-55 degrees of the retina. Optos imaging: Optos is an ultrawide field imaging platform which images up to 200 degrees of the retina. It uses both a green-light excitation wavelength of 532nm and a red-light excitation wavelength of 633nm with an emission filter of greater than 540nm to produce FAF images. Zeiss Clarus 700 imaging: Zeiss Clarus 700 is an ultrawide field imaging system with similar retinal coverage to that of Optos. It uses Broad Line Fundus Imaging to produce blue FAF images at excitation wavelengths of 435-500nm and green FAF images at wavelengths of 500-585nm
Age, Customized
less than 50 years
0 Participants
n=62 Participants
Age, Customized
50 years or greater
62 Participants
n=62 Participants
Sex: Female, Male
Female
43 Participants
n=62 Participants
Sex: Female, Male
Male
19 Participants
n=62 Participants
Region of Enrollment
United States
62 participants
n=62 Participants

PRIMARY outcome

Timeframe: Up to 75 minutes

Population: Participants (and eyes) with data available for pairwise comparison

Graders will independently measure area of GA from images of each device. The measurements (in mm²) will be compared between the devices.

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
n=61 eyes
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
n=61 eyes
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Comparison of Geographic Atrophy Area Measurements With Heidelberg Spectralis to Zeiss Clarus 700 and Optos California
8.33 millimeters squared
Standard Deviation 5.31
8.67 millimeters squared
Standard Deviation 5.48
7.86 millimeters squared
Standard Deviation 4.87
8.8 millimeters squared
Standard Deviation 5.46

PRIMARY outcome

Timeframe: Up to 75 minutes

Population: Participants (and eyes) with data available for pairwise comparison

Graders will independently measure area of GA from images of each device. The measurements (in mm²) will be compared between the devices.

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
n=61 eyes
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
n=61 eyes
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Comparison of Geographic Atrophy Area Measurements With Heidelberg Spectralis to Zeiss Clarus 700 and Optos California (Full Range Reported)
8.33 millimeters squared
Interval 1.33 to 19.2
8.67 millimeters squared
Interval 1.35 to 21.18
7.86 millimeters squared
Interval 1.36 to 19.84
8.83 millimeters squared
Interval 1.48 to 21.37

PRIMARY outcome

Timeframe: up to 75 mintues

Population: Participants (and eyes) with data available for pairwise comparison

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
n=61 eyes
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Number of Eyes With Greater Than 10% Difference in Geographic Atrophy Area Than Heidelberg RegionFinder
11 eyes
23 eyes
24 eyes

SECONDARY outcome

Timeframe: Up to 75 minutes

The presence of atrophy outside field 2 will be documented from the two ultrawide field imaging devices

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Prevalence of Atrophy Outside the Standard 30 Degrees in Clarus and Optos Ultrawide Field Images
4 eyes
4 eyes

SECONDARY outcome

Timeframe: Up to 75 minutes

The presence of abnormal autofluorescence outside field 2 will be documented from the two ultrawide field imaging devices

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Prevalence of Other Autofluorescence Abnormalities Outside the Standard 30 Degrees in Clarus and Optos Ultrawide Field Images
3 eyes
3 eyes

OTHER_PRE_SPECIFIED outcome

Timeframe: up to 75 minutes

Population: Participants (and eyes) with data available for pairwise comparison

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
n=61 eyes
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality
Subfoveal
29 eyes
28 eyes
33 eyes
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality
Multifocal
46 eyes
46 eyes
47 eyes
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality
Reticular pseudodrusen
35 eyes
19 eyes
33 eyes

OTHER_PRE_SPECIFIED outcome

Timeframe: up to 75 minutes

Population: Participants (and eyes) with data available for pairwise comparison

Outcome measures

Outcome measures
Measure
Heidelberg RegionFinder
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Heidelberg Manual
n=61 eyes
Spectralis FAF: 30 degree field of view, 488 excitation wavelength (nm), 500 emission filter (nm)
Optos Ultrawide Field FAF Images
n=61 eyes
200 degree field of view, 532, 633 excitation wavelength (nm), 540 emission filter (nm)
Clarus - Green
133 degree field of view, 500-585 excitation wavelength (nm), 630-750 emission filter (nm)
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality: Junctional Zone Pattern
None
1 eyes
3 eyes
2 eyes
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality: Junctional Zone Pattern
Focal
5 eyes
6 eyes
6 eyes
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality: Junctional Zone Pattern
Patchy
5 eyes
1 eyes
1 eyes
Geographic Atrophy Characteristics at Baseline Visit for Each Imaging Modality: Junctional Zone Pattern
Banded/Diffuse
50 eyes
51 eyes
52 eyes

Adverse Events

Heidelberg Standard Field

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Optos Ultrawide Field FAF Images

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Clarus - Green

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Amitha Domalpally, MD, PhD

University of Wisconsin School of Medicine and Public Health

Phone: (608) 262-1334

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place